Advertisement
U.S. Markets open in 5 hrs 57 mins

IRLAB Therapeutics AB (publ) (IRLAB-A.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
12.20-0.30 (-2.40%)
As of 09:18AM CEST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
41,585
5,678
61,136
207,782
0
-
Cost of Revenue
-
-
0
39,091
0
-
Gross Profit
-
-
61,136
168,691
0
-
Operating Expense
160,712
186,444
174,359
116,239
91,562
-
Operating Income
-119,127
-180,766
-113,223
52,452
-91,562
-
Net Non Operating Interest Income Expense
-329
2,927
-297
-369
-194
-
Pretax Income
-119,454
-177,839
-113,406
51,781
-91,653
-
Tax Provision
0
0
0
0
0
-
Net Income Common Stockholders
-119,454
-177,839
-113,406
51,781
-91,653
-
Diluted NI Available to Com Stockholders
-119,454
-177,839
-113,406
51,781
-91,653
-
Basic EPS
-2.19
-3.43
-2.19
1.00
-1.92
-
Diluted EPS
-2.19
-3.43
-2.19
1.00
-1.92
-
Basic Average Shares
51,832
51,868
51,832
51,748
47,678
-
Diluted Average Shares
51,832
51,868
51,832
51,748
47,678
-
Total Operating Income as Reported
-119,124
-180,765
-113,110
52,576
-91,458
-
Total Expenses
160,712
186,444
174,359
155,330
91,562
-
Net Income from Continuing & Discontinued Operation
-119,454
-177,839
-113,406
51,781
-91,653
-
Normalized Income
-119,454
-177,839
-113,406
51,781
-91,653
-
Interest Income
4,354
3,125
0
1
1
-
Interest Expense
4,683
198
297
370
195
-
Net Interest Income
-329
2,927
-297
-369
-194
-
EBIT
-114,771
-177,641
-113,109
52,151
-91,458
-
EBITDA
-110,317
-173,325
-108,330
55,625
-89,202
-
Reconciled Cost of Revenue
-
-
0
39,091
0
-
Reconciled Depreciation
4,454
4,316
3,982
3,474
2,256
-
Net Income from Continuing Operation Net Minority Interest
-119,454
-177,839
-113,406
51,781
-91,653
-
Total Unusual Items Excluding Goodwill
-
-
-
0
0
74
Total Unusual Items
-
-
-
0
0
74
Normalized EBITDA
-110,317
-173,325
-108,330
55,625
-89,202
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-